Back to Search
Start Over
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency.
- Source :
- Molecular Pharmaceutics; 2/6/2023, Vol. 20 Issue 2, p1247-1255, 9p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 15438384
- Volume :
- 20
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- Molecular Pharmaceutics
- Publication Type :
- Academic Journal
- Accession number :
- 161764735
- Full Text :
- https://doi.org/10.1021/acs.molpharmaceut.2c00923